Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 22, 2015

Study Completion Date

December 20, 2016

Conditions
VasculopathyAllograft
Interventions
PROCEDURE

Dobutamine stress echocardiography, coronarography, brachial arterial echography

DSE: cumulative doses of dobutamine (max = 40 µg/kg/min) and atropine (max = 1.5 mg), to reach a maximal heart rate under clinical, electrocardiographic and echocardiographic surveillancesCoronarography: invasive injection into coronary arteries of a radiological product showing a contrast visible on an x-ray. FMD: Flow-mediated dilatation of the brachial artery induced by 5-min forearm arterial occlusion

Trial Locations (1)

67091

Service de Physiologie et d'Explorations Fonctionnelles, Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT00384540 - Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling | Biotech Hunter | Biotech Hunter